REPORTS

Let’s Pullulate and Expand Your Business

Compounding Pharmacies Market - Global Professional Analysis and Forecast to 2026

Nov 07, 2019  |  223 PAGES  |  REPORT CODE: CMM230402
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Compounding Pharmacies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.1% during the forecast period.

This report presents the market size and development trends by detailing the Compounding Pharmacies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Compounding Pharmacies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Compounding Pharmacies industry and will help you to build a panoramic view of the industrial development.

Compounding Pharmacies Market, By Type:

  • Pain medications

  • Hormone replacement therapy

Compounding Pharmacies Market, By Application:

  • Ophthalmology

  • Urology

  • Oncology

  • Others

Some of the leading players are as follows:

  • Fresenius Kabi

  • B.Braun Medical

  • Wedgewood Village Pharmacy

  • ITC Compounding Pharmacy

  • Fagron

  • Village Compounding Pharmacies

  • Cantrell Drug company

  • PharMEDium Services

  • Lorraine’s Pharmacy

  • Institutional Pharmacy solutions

  • Rx3 Compounding Pharmacy

  • Mcguff Compounding Pharmacy Services

  • Doughtery’s Pharmacy

  • Pencol Compounding Pharmacy

  • Triangle Compounding Pharmacies

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Compounding Pharmacies Market: Technology Type Analysis

  • 4.1 Compounding Pharmacies Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Compounding Pharmacies Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pain medications

    • 4.3.2 Hormone replacement therapy

5 Compounding Pharmacies Market: Product Analysis

  • 5.1 Compounding Pharmacies Product Market Share Analysis, 2018 & 2026

  • 5.2 Compounding Pharmacies Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Compounding Pharmacies Market: Application Analysis

  • 6.1 Compounding Pharmacies Application Market Share Analysis, 2018 & 2026

  • 6.2 Compounding Pharmacies Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Ophthalmology

    • 6.3.2 Urology

    • 6.3.3 Oncology

    • 6.3.4 Others

7 Compounding Pharmacies Market: Regional Analysis

  • 7.1 Compounding Pharmacies Regional Market Share Analysis, 2018 & 2026

  • 7.2 Compounding Pharmacies Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Fresenius Kabi

    • 9.1.1 Fresenius Kabi Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 B.Braun Medical

    • 9.2.1 B.Braun Medical Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Wedgewood Village Pharmacy

    • 9.3.1 Wedgewood Village Pharmacy Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 ITC Compounding Pharmacy

    • 9.4.1 ITC Compounding Pharmacy Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Fagron

    • 9.5.1 Fagron Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Village Compounding Pharmacies

    • 9.6.1 Village Compounding Pharmacies Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Cantrell Drug company

    • 9.7.1 Cantrell Drug company Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 PharMEDium Services

    • 9.8.1 PharMEDium Services Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Lorraine’s Pharmacy

    • 9.9.1 Lorraine’s Pharmacy Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Institutional Pharmacy solutions

    • 9.10.1 Institutional Pharmacy solutions Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Rx3 Compounding Pharmacy

    • 9.11.1 Rx3 Compounding Pharmacy Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Mcguff Compounding Pharmacy Services

    • 9.12.1 Mcguff Compounding Pharmacy Services Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Doughtery’s Pharmacy

    • 9.13.1 Doughtery’s Pharmacy Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Pencol Compounding Pharmacy

    • 9.14.1 Pencol Compounding Pharmacy Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Triangle Compounding Pharmacies

    • 9.15.1 Triangle Compounding Pharmacies Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 104 Figures and 146 Tables)

  • Figure Pain medications Compounding Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Hormone replacement therapy Compounding Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Ophthalmology market, 2015 - 2026 (USD Million)

  • Figure Urology market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Compounding Pharmacies market, by country, 2015 - 2026 (USD Million)

  • Table North America Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table North America Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table North America Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Canada Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Canada Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Europe Compounding Pharmacies market, by country, 2015 - 2026 (USD Million)

  • Table Europe Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Europe Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Europe Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Germany Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Germany Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table France Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table France Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Italy Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Italy Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Spain Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Spain Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Compounding Pharmacies market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table China Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table China Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Japan Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Japan Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table India Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table India Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Compounding Pharmacies market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table MEA Compounding Pharmacies market, by country, 2015 - 2026 (USD Million)

  • Table MEA Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table MEA Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table MEA Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Compounding Pharmacies market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Compounding Pharmacies market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Compounding Pharmacies market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Fresenius Kabi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table B.Braun Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Wedgewood Village Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ITC Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fagron Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Village Compounding Pharmacies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cantrell Drug company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PharMEDium Services Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lorraine’s Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Institutional Pharmacy solutions Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Rx3 Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mcguff Compounding Pharmacy Services Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Doughtery’s Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pencol Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Triangle Compounding Pharmacies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top